Analyst Ratings for Chinook Therapeutics (KDNY)

KDNY Rating Summary

KDNY Price Target Summary

* Over Last 12-Mos
  |   Expand Research on KDNY
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $31.57 (+91%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/22/2021 Bloom Burton & Co.
» Updated 4/16/2021
Antonia Borovina New Coverage Buy (1)
(N/A)
40.00
(N/A)
18.33
(16.53)
-9.82% Details
1/6/2021 Wedbush
» Updated 5/13/2021
Laura Chico New Coverage Outperform
(N/A)
27.00
(28.00)
15.52
(16.53)
6.51% Details
Like KDNY Ratings? Also take a look at ADRO

KDNY Ratings News